Fig. 1From: Modifying oncolytic virotherapy to overcome the barrier of the hypoxic tumor microenvironment. Where do we stand?The map indicates the number of oncolytic virotherapy studies (ongoing or completed phase 2 or 3 clinical trials) based on region. Source https://clinicaltrials.gov/ Jun 2022Back to article page